Recombinant Human DCTN5 Protein，GST

DCTN5, a member of the dynactin complex, plays a crucial role in intracellular transport and cellular processes by linking cellular organelles to the dynein motor protein, facilitating efficient movement along microtubules. Research into DCTN5 has gained attention due to its implications in various neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), where mutations in the DCTN5 gene have been associated with disease onset and progression. Understanding the structure and function of DCTN5 is vital for elucidating its role in cytoplasmic transport and cellular homeostasis. Recent studies have focused on the recombinant expression of DCTN5 proteins to investigate their biochemical properties, interaction with other proteins within the dynactin complex, and potential alterations in mutant forms linked to disease. This research not only enhances our knowledge of the molecular mechanisms underlying neurodegeneration but also opens avenues for therapeutic interventions targeting the dysfunction of transport mechanisms in affected neurons. By developing DCTN5 recombinant proteins, scientists aim to establish models that can further probe its dynamics and interactions, providing insights into how disruptions in this pathway contribute to pathologies and advancing the understanding of neurodegenerative mechanisms. Consequently, DCTN5 remains a significant focus in neurobiological research, with the potential to yield impactful findings that could lead to novel strategies for diagnosis and treatment of associated diseases.